Image Skincare expanded its physician-developed, medical-grade Image MD collection with three new clinically proven formulas. 

The new Image MD products are designed to protect, soothe, and restore skin due to skin type or following professional treatments such as lasers and chemical peels, helping support sensitive or compromised skin while promoting optimal recovery and resilience.

New products are the Biotech Longevity Crème, Barrier Recovery Balm, and Gentile Cleansing Balm.

About the New Products

The Image MD Biotech Longevity Crème is a next-generation treatment to enhance the skin’s vitality over time. It’s powered by a NAD+ booster with anti-inflammatory properties and proprietary XOSM Technology. 

This treatment supports skin longevity by defending against the effects of internal and external stressors, facilitating repair functions resulting in visible improvement in wrinkles, rough texture, and age spots.

The Barrier Recovery Balm is designed to mimic the skin’s natural lipid barrier composition to accelerate and enhance recovery – whether it’s used as a daily treatment or post-procedure. 

The luxuriously silky, semi-occlusive formula received a National Rosacea Society Seal of Acceptance and National Eczema Association (NEA) Seal of Acceptance. 

The formula features the brand’s proprietary, patent-pending XOSM Technology to enhance ingredient performance, along with beta-glucan, colloidal oatmeal, and a 3-in-1 hydration complex to deliver deep comfort and moisture to provide relief from red, scaling skin.

Image Skincare’s Gentile Cleansing Balm is made for daily use or part of a post-treatment recovery regimen.

This professional-grade oil-based cleanser has a balm-to-milk texture and blends grapeseed oil, chamomile, vanilla, and a phyto antioxidant blend to gently remove surface impurities and residue, leaving skin soft, clean, and soothed.

The launches build upon the existing Image MD lineup, reinforcing the collection’s focus on advanced, results-driven anti-aging skincare.

Read Next

Lancome Announces Absolue Longevity MD Line